Volume 162, Issue 3, Pages (July 2015)

Slides:



Advertisements
Similar presentations
Cheng-Ming Sun, Edith Deriaud, Claude Leclerc, Richard Lo-Man  Immunity 
Advertisements

Volume 5, Issue 1, Pages (January 2009)
Volume 37, Issue 3, Pages (September 2012)
Volume 22, Issue 4, Pages e4 (October 2017)
Induction and role of regulatory CD4+CD25+ T cells in tolerance to the transgene product following hepatic in vivo gene transfer by Ou Cao, Eric Dobrzynski,
Chiara Martinoli, Andrea Chiavelli, Maria Rescigno  Immunity 
Volume 6, Issue 5, Pages (November 2009)
Volume 47, Issue 1, Pages e8 (July 2017)
by Silke Huber, Reinhard Hoffmann, Femke Muskens, and David Voehringer
by Daniel L. Barber, Katrin D. Mayer-Barber, Lis R. V
Sequential Polarization and Imprinting of Type 1 T Helper Lymphocytes by Interferon-γ and Interleukin-12  Edda G. Schulz, Luca Mariani, Andreas Radbruch,
Simple conditioning with monospecific CD4+CD25+ regulatory T cells for bone marrow engraftment and tolerance to multiple gene products by David-Alexandre.
Volume 40, Issue 2, Pages (February 2014)
Volume 33, Issue 1, Pages (July 2010)
Maternal-Derived Hepatitis B Virus e Antigen Alters Macrophage Function in Offspring to Drive Viral Persistence after Vertical Transmission  Yongjun Tian,
Volume 34, Issue 2, Pages (February 2011)
Volume 42, Issue 2, Pages (February 2015)
Offspring’s Tolerance of Mother Goes Viral
Volume 28, Issue 1, Pages (January 2008)
Volume 141, Issue 5, Pages (November 2011)
Volume 6, Issue 4, Pages (April 1997)
Volume 150, Issue 1, Pages (July 2012)
Volume 153, Issue 4, Pages (May 2013)
Volume 21, Issue 3, Pages (September 2004)
Volume 41, Issue 1, Pages (July 2014)
Volume 33, Issue 1, Pages (July 2010)
Volume 45, Issue 1, Pages (July 2016)
Humoral Immunity Due to Long-Lived Plasma Cells
Volume 28, Issue 6, Pages (June 2008)
Volume 29, Issue 1, Pages (July 2008)
Volume 6, Issue 5, Pages (November 2009)
Volume 35, Issue 4, Pages (October 2011)
Regulatory T Cells Control Antigen-Specific Expansion of Tfh Cell Number and Humoral Immune Responses via the Coreceptor CTLA-4  James Badger Wing, Wataru.
Volume 29, Issue 6, Pages (December 2008)
Volume 28, Issue 5, Pages (May 2008)
Volume 27, Issue 3, Pages (September 2007)
Volume 13, Issue 6, Pages (November 2015)
Francis Coffey, Boris Alabyev, Tim Manser  Immunity 
Volume 5, Issue 1, Pages (January 2009)
Volume 38, Issue 6, Pages (June 2013)
T Cell–Mediated Elimination of B7.2 Transgenic B Cells
Transcutaneous Gene Gun Delivery of hNC16A Induces BPAG2-Specific Tolerance  Monika Ettinger, Doris Peckl-Schmid, Christina Gruber, Martin Laimer, Josef.
Volume 32, Issue 1, Pages (January 2010)
Opposing Effects of TGF-β and IL-15 Cytokines Control the Number of Short-Lived Effector CD8+ T Cells  Shomyseh Sanjabi, Munir M. Mosaheb, Richard A.
Eric A Butz, Michael J Bevan  Immunity 
Volume 43, Issue 5, Pages (November 2015)
Volume 39, Issue 1, Pages (July 2013)
T Cells with Low Avidity for a Tissue-Restricted Antigen Routinely Evade Central and Peripheral Tolerance and Cause Autoimmunity  Dietmar Zehn, Michael.
Volume 19, Issue 7, Pages (July 2011)
Matthew A. Williams, Eugene V. Ravkov, Michael J. Bevan  Immunity 
Jennifer K. Broom, Andrew M. Lew, Hiroaki Azukizawa, Tony J
Volume 41, Issue 4, Pages (October 2014)
Volume 12, Issue 2, Pages (July 2015)
Susan M. Kaech, Scott Hemby, Ellen Kersh, Rafi Ahmed  Cell 
Volume 32, Issue 1, Pages (January 2010)
Volume 10, Issue 1, Pages (July 2011)
Volume 40, Issue 5, Pages (May 2014)
Volume 28, Issue 5, Pages (May 2008)
Volume 38, Issue 6, Pages (June 2013)
Volume 87, Issue 2, Pages (October 1996)
Volume 17, Issue 7, Pages (November 2016)
Notch 1 Signaling Regulates Peripheral T Cell Activation
Volume 25, Issue 4, Pages (April 2017)
Mattias Svensson, Asher Maroof, Manabu Ato, Paul M. Kaye  Immunity 
Volume 23, Issue 4, Pages (October 2005)
Analysis of Type 2 Immunity In Vivo with a Bicistronic IL-4 Reporter
Memory CD8+ T Cells Undergo Peripheral Tolerance
Volume 4, Issue 5, Pages (May 1996)
Volume 25, Issue 4, Pages (October 2006)
Volume 45, Issue 5, Pages (November 2016)
Presentation transcript:

Volume 162, Issue 3, Pages 505-515 (July 2015) Cross-Generational Reproductive Fitness Enforced by Microchimeric Maternal Cells  Jeremy M. Kinder, Tony T. Jiang, James M. Ertelt, Lijun Xin, Beverly S. Strong, Aimen F. Shaaban, Sing Sing Way  Cell  Volume 162, Issue 3, Pages 505-515 (July 2015) DOI: 10.1016/j.cell.2015.07.006 Copyright © 2015 Elsevier Inc. Terms and Conditions

Cell 2015 162, 505-515DOI: (10.1016/j.cell.2015.07.006) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 1 Developmental Exposure to Maternal Tissue Primes Expanded NIMA-Specific FOXP3+ Tregs (A) Representative plots showing the gating strategy used to identify I-Ab:2W1S specific among CD4+ T cells (top), FOXP3+ Tregs among I-Ab:2W1S-specific CD4+ T cells (middle), and composite data (bottom) for percent FOXP3+ among CD4+ T cells with I-Ab:2W1S specificity (filled) compared with bulk CD4+ T cells (open) in the spleen plus peripheral lymph nodes of naive (blue), NIMA-2W1S (red), NIPA-2W1S (green), or 2W1S-self (gray) 8-week-old adult mice. (B) Total number of I-Ab:2W1S-specific FOXP3+ Tregs (top) and CD4+ T cells (bottom) for each group of mice described in (A). (C) Percent Helioshi among I-Ab:2W1S-specific (red line) or bulk (gray shaded) FOXP3+ CD4+ T cells for each group of mice described in (A). (D) Mating strategy for generating genetically identical NIMA-2W1S offspring born to either MHC class II I-Ab/b (I-Ab:2W1S55-68 peptide presented by cells of both maternal and fetal origin) or I-Ad/d (I-Ab:2W1S55-68 peptide only presented by cells of fetal origin) haplotype mothers, and composite data for percent FOXP3+ among I-Ab:2W1S-specific CD4+ T cells and Helioshi among I-Ab:2W1S-specific FOXP3+ cells for each group of NIMA-2W1S (red) compared with naive (blue) mice. (E) Percent FOXP3+ among I-Ab:2W1S-specific CD4+ T cells, and Helioshi among I-Ab:2W1S-specific FOXP3+ cells for each group of cross-fostered offspring exposed to 2W1S-OVA in utero and/or postnatally through breastfeeding by 2W1S-OVA+ mothers. Each point represents the result from an individual female mouse, and these data are representative of at least three separate experiments each with similar results. Bars, mean ± 95% confidence interval. ∗∗p < 0.01, ∗∗∗p < 0.001. See also Figure S1. Cell 2015 162, 505-515DOI: (10.1016/j.cell.2015.07.006) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 2 NIMA-Specific Treg Expansion Requires Persistent Postnatal Exposure to Microchimeric Maternal Cells (A) Maternal 2W1S-OVA+ microchimeric cell encoding DNA levels in each tissue of naive (blue filled), NIMA-2W1S (red filled), or NIMA-2W1S mice treated with anti-OVA depleting antibody (red open). (B) Cell surface OVA expression levels among splenocytes from 2W1S-OVA+ compared with naive control mice after staining with anti-OVA (red line) or rabbit IgG isotype (gray shaded) antibodies. (C) Representative plots and composite data for FOXP3+ Tregs among I-Ab:2W1S-specific CD4+ T cells, and Helios expression among I-Ab:2W1S-specific FOXP3+ cells for each group of mice described in (A). Each point represents the result from an individual female mouse at 8 weeks of age, and these data are representative of at least three separate experiments each with similar results. Bars, mean ± 95% confidence interval. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001. L.O.D., limit of detection. See also Figure S2. Cell 2015 162, 505-515DOI: (10.1016/j.cell.2015.07.006) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 3 Expanded NIMA-Specific Treg Accumulation in Female Offspring Parallels Discordant Maternal Cell Microchimerism in Gender-Specific Reproductive Tissue (A) 2W1S-OVA+ encoding DNA levels in each tissue among NIMA-2W1S female (red circle), littermate 2W1S-NIMA male (red triangle), naive female (blue circle) and naive male (blue triangle) mice. (B) Representative plots and composite data showing I-Ab:2W1S-specific CD4+ T cells (top), FOXP3+ Tregs among I-Ab:2W1S-specific CD4+ T cells (middle), and Helios expression among Tregs with I-Ab:2W1S specificity (red line) or bulk specificity (gray shaded) among NIMA-2W1S female compared with NIMA-2W1S littermate male mice. Each point represents the result from an individual mouse at 8 weeks of age, and these data are representative of at least three separate experiments each with similar results. Bars, mean ± 95% confidence interval. ∗p < 0.05, ∗∗p < 0.01. L.O.D., limit of detection. Cell 2015 162, 505-515DOI: (10.1016/j.cell.2015.07.006) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 4 NIMA-Specific Treg Expansion Accelerated during Pregnancy with NIMA-Matched Fetal Antigen Stimulation Representative plots and composite data showing I-Ab:2W1S-specific CD4+ T cells (top), FOXP3+ Tregs among I-Ab:2W1S-specific CD4+ T cells (middle), and composite data for percent and number of FOXP3+ CD4+ T cells with I-Ab:2W1S specificity in virgin and midgestation (E11.5) naive female (blue) compared with NIMA-2W1S (red) female mice after mating with 2W1S-OVA+ transgenic male mice or non-transgenic controls. Each point represents the result from an individual mouse, these data are representative of at least three separate experiments each with similar results. Bars, mean ± 95% confidence interval. ∗∗∗p < 0.001. Cell 2015 162, 505-515DOI: (10.1016/j.cell.2015.07.006) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 5 Overlap between NIMA and Paternal-Fetal Alloantigen Protects against Fetal Resorption and In Utero Bacterial Invasion following Prenatal Infection (A) Percent fetal resorption (top) and average recoverable bacterial CFUs from each concepti per litter (bottom) five days following L. monocytogenes intravenous maternal infection initiated midgestation (E11.5) for naive female (blue) compared with NIMA-H-2d-(2W1S-OVA) (red) female mice during allogeneic pregnancy sired by H-2d or third party H-2k males, or depletion of microchimeric 2W1S-OVA+ maternal cells with anti-OVA antibody prior to mating. (B) Percent fetal resorption (top) and average recoverable bacterial CFUs from each concepti per litter (bottom) five days following L. monocytogenes intravenous maternal infection initiated midgestation (E11.5) for naive female (blue) compared with NIMA-H-2k-(2W1S-OVA) (red) female mice during allogeneic pregnancy sired by H-2k or third party H-2d males, or depletion of microchimeric 2W1S-OVA+ maternal cells with anti-OVA antibody prior to mating. Each point represents the result from an individual mouse, and these data are representative of at least three separate experiments each with similar results. Bars, mean ± 95% confidence interval. ∗∗∗p < 0.001. L.O.D., limit of detection. See also Figure S3. Cell 2015 162, 505-515DOI: (10.1016/j.cell.2015.07.006) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 6 Overlap between NIMA and Paternal-Fetal Antigen Protects against Fetal Wastage Triggered by Partial Depletion of Maternal FOXP3+ Regulatory T Cells (A) Percent fetal resorption for naive (blue) FOXP3WT/WT and FOXP3DTR/WT female mice compared with each group of NIMA-H-2d FOXP3DTR/WT (red) female mice five days after initiating diphtheria toxin during allogeneic pregnancy sired by H-2d or third party H-2k males, or depletion of microchimeric 2W1S-OVA+ maternal cells with anti-OVA antibody prior to mating. (B) Percent fetal resorption for naive (blue) FOXP3WT/WT and FOXP3DTR/WT female mice compared with each group of NIMA-H-2k FOXP3DTR/WT (red) female mice five days after initiating diphtheria toxin during allogeneic pregnancy sired by H-2k or third party H-2d males, or depletion of microchimeric 2W1S-OVA+ maternal cells with anti-OVA antibody prior to mating. Each point represents the result from an individual mouse, these data are representative of at least three separate experiments each with similar results. Bars, mean ± 95% confidence interval. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001. See also Figure S4. Cell 2015 162, 505-515DOI: (10.1016/j.cell.2015.07.006) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 7 Cross-Generational Reproductive Fitness Enforced by Vertically Transferred Microchimeric Maternal Cells in Eutherian Placental Mammals In traditional Mendelian genetics (top), pregnancies among female offspring are equally susceptible to fetal wastage or other complications stemming from disruptions in fetal tolerance regardless of paternal MHC haplotype specificity. Comparatively, persistent postnatal maintenance of tolerogenic microchimeric maternal cells in female offspring promotes cross-generational reproductive fitness (bottom) by selectively protecting against fetal wastage during next-generation pregnancies sired by males with shared overlapping NIMA specificity. Cell 2015 162, 505-515DOI: (10.1016/j.cell.2015.07.006) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure S1 Mating Strategy that Transform 2W1S55-68 and OVA into Surrogate NIMA, NIPA, or Self Antigens, Related to Figure 1 (A) Schematic of OVA-2W1S transgenic expression construct. The coding sequence for 2W1S55-68 peptide was embedded with a membrane-bound form of chicken ovalbumin. Adapted from (Moon et al., 2011). (B) Female mice on the C57BL/6 (H-2b/b I-Ab/b) background heterozygous for the transgene encoding constitutive cell surface expression of a recombinant protein containing ovalbumin (OVA) and 2W1S55-68 peptide (2W1S-OVA+/−) were mated with non-transgenic Balb/c (H-2d/d I-Ad/d) male mice, thereby transforming OVA and 2W1S55-68 into non-inherited maternal antigens (NIMA) in half of the offspring. (C) Non-transgenic female C57BL/6 (H-2b/b I-Ab/b) mice were mated with male mice on the Balb/c (H-2d/d I-Ad/d) background heterozygous for the same transgene that encodes constitutive cell surface expression of a recombinant protein containing ovalbumin (OVA) and 2W1S55-68 peptide (2W1S-OVA+/−), thereby transforming OVA and 2W1S55-68 into non-inherited paternal antigens (NIPA) in half of the offspring. (D) F1 offspring from mating between non-transgenic female C57BL/6 (H-2b/b I-Ab/b) and male Balb/c (H-2d/d I-Ad/d) mice were used as naive controls. Cell 2015 162, 505-515DOI: (10.1016/j.cell.2015.07.006) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure S2 Enumeration and Depletion of 2W1S-OVA+ Cells, Related to Figure 2 (A) Representative real-time PCR (left) and standard curve (right) demonstrating the linear relationship between undiluted OVA+ DNA (from 2W1S-OVA+ mice), and serial 10-fold dilutions of OVA+ DNA added to OVA− control DNA (from naive C57BL/6 control mice). (B) Splenocytes from 2W1S-OVA+ CD45.1+ mice were adoptively transferred into isogenic CD45.2+ C57BL/6 recipients treated with depleting anti-OVA or rabbit IgG isotype control antibody (650 μg each per mouse). Three days after cell transfer and antibody administration, 2W1S-OVA+ CD45.1+ donor cells among splenocytes remaining in each group were evaluated by flow cytometry. Cell 2015 162, 505-515DOI: (10.1016/j.cell.2015.07.006) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure S3 Breeding Strategy for Generating Mice to Investigate Pregnancy Outcomes when MHC Haplotype Alleles and 2W1S-OVA Are Simultaneously Transformed into Surrogate NIMA, Related to Figure 5 Female H-2d/d haplotype mice on the C57BL/6 background (B6.C-H2d/bByJ) were mated with H-2b/b haplotype 2W1S-OVA+ C57BL/6 male mice (Generation 1 breeding). All F1 offspring are H-2b/d, and females heterozygous for the 2W1S-OVA expression transgene were used for breeding with C57BL/6 (H-2b/b) male mice (Generation 2 breeding). Thereafter, 25% of offspring do not inherit genes encoding H-2d haplotype alleles or 2W1S-OVA (H-2d and 2W1S-OVA simultaneously transformed into surrogate NIMA). Pregnancy outcomes among the latter group of H-2b/b female mice were evaluated during allogeneic pregnancy sired by Balb/c (H-2d/d; fetal antigen with shared NIMA specificity) or CBA/J (H-2k/k, no overlap between NIMA and fetal antigen) (Generation 3 experimental breeding). For transforming H-2k haplotype antigens into NIMA in H-2b/b mice, female H-2k/k haplotype mice (B6.Ak-H2k/J) were substituted for H-2d/d B6.C-H2d/bByJ mice beginning in generation 1 breeding using this mating scheme. Cell 2015 162, 505-515DOI: (10.1016/j.cell.2015.07.006) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure S4 Strategy for Generating FOXP3DTR/WT Mice to Investigate Pregnancy Outcomes after Partial Depletion of Maternal FOXP3+ Tregs when MHC Haplotype Alleles and 2W1S-OVA Are Simultaneously Transformed into Surrogate NIMA, Related to Figure 6 Female H-2d/d haplotype mice on the C57BL/6 background (B6.C-H2d/bByJ) were mated with H-2b/b haplotype 2W1S-OVA+ C57BL/6 male mice (Generation 1 breeding). All F1 offspring are H-2b/d, and females heterozygous for the 2W1S-OVA expression transgene were used for breeding with FOXP3DTR/o male mice on the C57BL/6 (H-2b/b) background (Generation 2 breeding). Thereafter, all female progeny are FOXP3DTR/WT, and 25% of offspring do not inherit genes encoding H-2d haplotype alleles or 2W1S-OVA (H-2d and 2W1S-OVA simultaneously transformed into surrogate NIMA). Pregnancy outcomes among the latter group of H-2b/b female mice were evaluated after partial depletion of bulk maternal FOXP3+ Tregs with diphtheria toxin administration beginning midgestation during allogeneic pregnancy sired by Balb/c (H-2d/d; fetal antigen encompasses NIMA specificity) or CBA/J (H-2k/k, no overlap between NIMA and fetal antigen) (Generation 3 experimental breeding). For transforming H-2k haplotype antigens into NIMA in H-2b/b mice, female H-2k/k haplotype mice (B6.Ak-H2k/J) were substituted for H-2d/d B6.C-H2d/bByJ mice beginning in generation 1 breeding using this mating scheme. Cell 2015 162, 505-515DOI: (10.1016/j.cell.2015.07.006) Copyright © 2015 Elsevier Inc. Terms and Conditions